Zolbetuximab plus CAPOX in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: the randomized, phase 3 GLOW trialManish A. Shah, Rui‐Hua Xu, Peter C. Enzinger et al.|Nature Medicine|2023Cited by 541
N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial CellsJohn K. Lee, Owen N. Witte, John W. Phillips et al.|Cancer Cell|2016Cited by 416
Prostate epithelial cell of origin determines cancer differentiation state in an organoid transformation assayJung Wook Park, Owen N. Witte|Proceedings of the National Academy of Sciences|2016Cited by 133